• Fri, February 21, 2025

by: MSN

Is Eli Lilly and Company (LLY) the Best Non-Tech Stock to Buy Now for Long Term?

We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other non-tech stocks.

by: WOPRAI

Short squeeze is starting in shares of SERV at $13.39, after crossing above the $13.325 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SEAS at $54.26, after crossing above the $41.863 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of RNW at $6.405, after crossing above the $6.38 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of RE at $338.72, after crossing above the $277.795 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of RCRT at $2.57, after crossing above the $0.791 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PWFL at $7.71, after crossing above the $4.631 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PRMW at $33, after crossing above the $16.562 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PRMO at $0.18, after crossing above the $0.001 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PNM at $51.48, after crossing above the $44.406 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PDYPF at $286.925, after crossing above the $159.567 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ORCC at $15.48, after crossing above the $13.054 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of OFC at $26.76, after crossing above the $25.687 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of OCN at $32.52, after crossing above the $5.495 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of OCEL at $2.85, after crossing above the $0.023 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of OAS at $115.655, after crossing above the $2.393 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of NYCB at $12.915, after crossing above the $8.302 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of NRZ at $11.955, after crossing above the $8.968 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of NR at $6.745, after crossing above the $4.304 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MMMB at $7.01, after crossing above the $2.632 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MCG at $7.685, after crossing above the $6.591 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MBCN at $25.61, after crossing above the $25.141 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of LYL at $2.231, after crossing above the $2.165 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of KNW at $2, after crossing above the $0.303 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of JBT at $121.62, after crossing above the $108.029 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of INT at $27.64, after crossing above the $27.351 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of HG at $18.25, after crossing above the $18.204 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of HEAR at $18.89, after crossing above the $17.773 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of GLT at $21.85, after crossing above the $4.711 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of GEOS at $8.736, after crossing above the $8.716 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of EPAZ at $0.313, after crossing above the $0.007 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CPSI at $28.05, after crossing above the $24.559 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CNHI at $13.305, after crossing above the $13.029 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CECE at $24.284, after crossing above the $7.447 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CAJ at $34.096, after crossing above the $21.5 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BSIG at $26.02, after crossing above the $20.416 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BRP at $40.73, after crossing above the $26.082 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BOW at $31.92, after crossing above the $31.798 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BGNE at $241.31, after crossing above the $217.263 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ATAX at $12.108, after crossing above the $6.327 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ANTM at $390.68, after crossing above the $340.105 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ALRN at $2.7, after crossing above the $1.284 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of AESI at $21.875, after crossing above the $21.846 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ADES at $5.675, after crossing above the $5.093 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ACST at $3.43, after crossing above the $0.594 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ACOGF at $6.58, after crossing above the $0.434 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ABB at $58.33, after crossing above the $29.262 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of AACIW at $0.606, after crossing above the $0.137 Trigger Price

Is Eli Lilly and Company (LLY) the Best Non-Tech Stock to Buy Now for Long Term?

We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other non-tech stocks.
The article from MSN Money discusses whether Eli Lilly and Company (LLY) is the best non-tech stock to buy for long-term investment. It highlights Eli Lilly's strong performance in the pharmaceutical sector, driven by its innovative pipeline, particularly with drugs like Mounjaro for diabetes and potential treatments for Alzheimer's. The company has shown robust financial health with significant revenue growth and a promising outlook due to its focus on high-demand therapeutic areas like oncology, immunology, and neuroscience. Despite its high valuation, the article suggests that Eli Lilly's consistent innovation, strategic acquisitions, and a solid dividend history make it an attractive option for investors looking for growth outside the tech sector. However, it also notes the inherent risks in the pharmaceutical industry, such as regulatory hurdles and competition, but concludes that Eli Lilly's diversified portfolio and ongoing research could position it well for long-term gains.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/top-stocks/is-eli-lilly-and-company-lly-the-best-non-tech-stock-to-buy-now-for-long-term/ar-AA1zw7H4

Like: 👍